Keyphrases
Acute Leukemia
28%
Acute Lymphoblastic Leukemia
100%
Acute Lymphoblastic Leukemia Cells
18%
Acute Myeloid Leukemia
79%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
48%
B-cell Acute Lymphoblastic Leukemia (B-ALL)
17%
BCP-ALL
27%
Bone Marrow
25%
CD19
53%
CD34+
40%
Cell Population
16%
Childhood Acute Lymphoblastic Leukemia
38%
Childhood Leukemia
21%
Children with Cancer
14%
Chimeric Antigen Receptor T Cells (CAR-T)
24%
Drug Development
19%
Engraftment
29%
Event-free Survival
18%
Ewing Sarcoma Family of Tumors
48%
Farber Disease
17%
Flow Cytometric
18%
Gene Therapy
16%
Hematopoietic Cells
18%
Hematopoietic Stem Cell Transplantation
26%
High Risk
20%
Immune-deficient Mice
27%
Immunophenotypic Profile
14%
Immunophenotyping
20%
In Vivo Model
20%
Leukemia
78%
Leukemia Patients
27%
Leukemic Cells
16%
Leukemic Stem Cells
20%
Minimal Residual Disease
18%
Older Adults
18%
Pediatric
42%
Pediatric Cancer
14%
RAS Pathway
21%
Relapsed or Refractory
25%
SCID Mice
33%
Selumetinib
15%
Stem Cell Population
29%
Stem Cell Transplantation
24%
Stem Cells
23%
T Cells
20%
T-cell Acute Lymphoblastic Leukemia (T-ALL)
16%
Transplantation
21%
Tumor
29%
Tumor Cell Lines
15%
Tumor Cells
21%
Medicine and Dentistry
(3 Iodobenzyl)guanidine
11%
3 Hydroxyephedrine
11%
Acute Lymphoblastic Leukemia
85%
Acute Myelogenous Leukemia
26%
Acute Myeloid Leukemia
70%
Adolescence
20%
Allogeneic Hematopoietic Stem Cell Transplantation
14%
Allogeneic Stem Cell Transplantation
12%
Auer Rod
11%
B Cell
33%
Cancer
15%
Carbon 11
11%
Cell Population
23%
Central Nervous System
15%
Chemotherapy
20%
Childhood Cancer
13%
Clinical Trial
17%
Dexamethasone
11%
Disease
20%
Down Syndrome
17%
Event Free Survival
11%
Ewing Sarcoma
19%
Farber Disease
17%
Hematopoietic Cell
13%
Hematopoietic Stem Cell Transplantation
26%
Immunity
10%
Immunotherapy
22%
Iodine 123
11%
Leukemia
43%
Leukemia in Children
13%
Malignant Neoplasm
15%
Metastatic Carcinoma
18%
Neoplasm
36%
Normal Stem Cell
11%
Oncology
16%
Pediatric Cancer
14%
Pediatrics
53%
Personalized Medicine
11%
Positron Emission Tomography-Computed Tomography
12%
Precursor
28%
Radioactive Tracer
11%
SCID Mouse
20%
Single Photon Emission Computed Tomography-Computed Tomography
11%
Stem Cell
41%
Stem Cell Therapy
16%
Sympathetic Nervous System
11%
T Cell
21%
Transplantation
16%
Whole Body PET
12%
Xenograft
21%
Immunology and Microbiology
Adolescence
11%
Allogeneic Hematopoietic Stem Cell Transplantation
20%
Allogeneic Stem Cell Transplantation
24%
Antigen Expression
7%
Autoimmune Hemolytic Anemia
11%
B Cell
48%
Bone Marrow Cell
9%
Cancer Stem Cell
13%
CD11a
7%
CD19
51%
CD28
9%
CD34
62%
CD38
8%
Cell Adhesion Proteins
9%
Cell Death
8%
Cell Level
12%
Cell Population
32%
Cell Subpopulation
14%
Cell Transplantation
11%
Central Nervous System
17%
Chimera
13%
Conditioning
11%
Cytokine
21%
DNA Content
8%
Engraftment
30%
Epstein Barr Virus
16%
Event Free Survival
16%
Hematopoiesis
23%
Hematopoietic Cell
30%
Hematopoietic Stem Cell Transplantation
14%
High Risk Population
8%
Human Cell
12%
Immunity
7%
Immunology
12%
Immunotherapy
25%
Leukemia Cell
24%
Lineages
22%
Maturation
8%
Myeloid
46%
NOD SCID Mouse
11%
Precursor
47%
SCID Mouse
30%
Stem Cell
81%
Stem Cell Transplantation
24%
Survival Rate
9%
T Cell
32%
T Cell Receptor
7%
Tumor Cell
27%
Tumor Cell Line
14%
Xenograft
15%